Status:
UNKNOWN
Cabergoline Effect on Blood Sugar in Type 2 Diabetics
Lead Sponsor:
Mashhad University of Medical Sciences
Conditions:
Diabetes Type 2
Eligibility:
All Genders
Phase:
NA
Brief Summary
Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.
Eligibility Criteria
Inclusion
- Type 2 diabetes
- HbA1C\>7
Exclusion
- HbA1C\>10
- Psychiatric disorders
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01459601
Start Date
January 1 2012
End Date
February 1 2012
Last Update
October 25 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.